Rhumbline Advisers Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Rhumbline Advisers

$105 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$144.95 - $152.29 $2.15 Million - $2.25 Million	14,804 Added 18.63%	94,287 $14.3 Million
Q2 2022 Aug 11, 2022	BUY	$83.14 - $145.99 $1.41 Million - $2.48 Million	17,015 Added 27.24%	79,483 $11.6 Million
Q1 2022 May 12, 2022	SELL	$110.08 - $142.92 $147,947 - $192,084	-1,344 Reduced 2.11%	62,468 $7.41 Million
Q4 2021 Feb 10, 2022	SELL	$99.73 - $148.48 $34,606 - $51,522	-347 Reduced 0.54%	63,812 $8.79 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $239,315 - $336,301	2,421 Added 3.92%	64,159 $8.91 Million
Q2 2021 Aug 05, 2021	BUY	$65.78 - $105.02 $648,656 - $1.04 Million	9,861 Added 19.01%	61,738 $5.99 Million
Q1 2021 May 06, 2021	SELL	$64.07 - $91.75 $441,442 - $632,157	-6,890 Reduced 11.72%	51,877 $3.55 Million
Q4 2020 Feb 10, 2021	BUY	$65.07 - $98.24 $142,438 - $215,047	2,189 Added 3.87%	58,767 $5.04 Million
Q3 2020 Nov 12, 2020	SELL	$59.04 - $77.95 $789,010 - $1.04 Million	-13,364 Reduced 19.11%	56,578 $3.68 Million
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $412,145 - $1.05 Million	14,207 Added 25.49%	69,942 $5.11 Million
Q1 2020 May 06, 2020	BUY	$27.51 - $57.29 $122,887 - $255,914	4,467 Added 8.71%	55,735 $1.9 Million
Q4 2019 Feb 05, 2020	BUY	$40.86 - $57.65 $131,936 - $186,151	3,229 Added 6.72%	51,268 $2.79 Million
Q3 2019 Oct 23, 2019	BUY	$37.38 - $49.47 $187,722 - $248,438	5,022 Added 11.67%	48,039 $2 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $134,370 - $226,292	3,377 Added 8.52%	43,017 $1.88 Million
Q1 2019 May 01, 2019	BUY	$34.52 - $53.29 $99,935 - $154,274	2,895 Added 7.88%	39,640 $2.04 Million
Q4 2018 Jan 31, 2019	BUY	$29.75 - $42.9 $374,463 - $539,982	12,587 Added 52.1%	36,745 $1.36 Million
Q3 2018 Nov 07, 2018	SELL	$32.79 - $43.0 $44,430 - $58,265	-1,355 Reduced 5.31%	24,158 $907,000
Q2 2018 Aug 06, 2018	SELL	$23.62 - $42.29 $57,160 - $102,341	-2,420 Reduced 8.66%	25,513 $1.01 Million
Q1 2018 May 02, 2018	BUY	$22.49 - $34.56 $430,908 - $662,169	19,160 Added 218.4%	27,933 $720,000
Q4 2017 Feb 09, 2018	SELL	$20.44 - $35.56 $36,526 - $63,545	-1,787 Reduced 16.92%	8,773 $237,000
Q3 2017 Nov 06, 2017	BUY	$23.54 - $38.21 $248,582 - $403,497	10,560	10,560 $395,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account